We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
GymBuddy is an online platform that enables consumers to find, book, and attend a gym location, services, or products offered and operated by fitness studios, gyms, trainers, venues, or other third parties. Users can easily, through filtered searches on the app, view descriptions, and contact information of specialists within the fitness industry such as personal trainers, nutritionists, and physiotherapists. The UK fitness industry alone is currently worth over £5 billion. Based on recent statistics, the average gym membership in the UK costs members £40 a month, which often ties them into lengthy contracts. The GymBuddy app will enter the Health & Fitness club sector as a multi-gym membership feature that gives users access to gyms and various fitness plans, without the need for bricks-and-mortar locations under its brand. The company is seeking an investment of £400,000 to expand its brand identity and bring more users to its ecosystem to generate profits.

Pitch Rated

30%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
Screach provides consumer focused venues with the ability to intelligently engage and interact with their customers via installed digital displays (TVs) and mobile phones. The Screen Reach software dynamically changes the screen content to improve its effectiveness in driving more sales by displaying relevant engaging content and promotions. 
days to go: Expired investment: £590,000
AgPlus has created a diagnostic platform for detecting human diseases and delivering laboratory instrument results instantly, whilst keeping in mind the business requirements and unmet requirements. The company works in collaboration with leading diagnostics companies to improve and share products quickly and globally. It aims is to become known as a leader in Point of Care diagnosis.
days to go: Expired investment: £65,004
Ablatus Therapeutics is a MedTech company developing a one-of-a-kind tissue ablation platform known as Bimodal Electric Tissue Ablation (BETA). This technology has been designed to overcome the limitations of existing products by offering ablation solutions in oncology (tumours) as well as non-oncology targets. With the proceeds, the company will finish the final elements of engineering of the generator and probe. It will also deliver formal safety test data that is a prerequisite for subsequent clinical trials.
days to go: Expired investment: Withheld
Adapttech aim to reduce the number of sessions needed to adjust a prosthetic to it’s owner, making prosthetics more comfortable at a much faster rate. Their technology uses a laser scanner combined wearale sensors to determine where the socket needs adjustments.
days to go: Expired investment: £1,225,000
End-to-end platform that enables content owners to profitably deliver video content direct-2-user in a complex multi-device world.
days to go: Expired investment: £510,000
AMUTRI LTD specializes in quick 3D visualization through CAD and BIM files. They are committed to creating the largest database of design data, tackling the difficulty of acquiring elusive building and product design information. This data plays a crucial role in driving innovations like AI-powered design, robot training, and gaming asset generation. Moreover, the company aims to address the time-consuming tasks carried out by 3D Visualisers and Artists.
days to go: Expired investment: £500,000
Ancon is designed to detect trace elements of things such as explosives, drugs and chemical weapons in the air. Ancon manufactures equipment and components that are up to 10,000 times more sensitive then anything else on the market.
days to go: Expired investment: £1,043,525
Ancon manufacture equipment and components that detect trace elements of explosives, drugs and chemical weapons in the air. Ancons technology is roughly 10,000 times more sensitive than anything currently on the market.
days to go: Expired investment: £1,043,525
Ancon technologies manufacture equipment and components to detect trace elements in the air, things such as explosives, drugs and chemical weapons. The technology created by Ancon is around 10,000x more sensitive than anything on the market at the moment. 
days to go: Expired investment: £457,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph